Company Overview
| Stock Name | Ec Healthcare |
|---|---|
| Stock Code | 02138 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 主要專注於提供醫學美容服務,如整形外科手術、微整形療程及醫生操作的能量儀器療程,並提供牙科、中醫、眼科、準醫療服務、傳統美容服務及護膚美容產品。 |
| Listing Date | 2016-03-11 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港鰂魚涌英皇道979號太古坊德宏大廈20樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | umhgp.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 3.03 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 1e-05 / shares |
| Offer Period | 2016-03-01 to 2016-03-04 |
| Global Offering Shares | 245,000,000 shares |
| HK Public Offer Shares (Initial) | 24,500,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 220,500,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 980,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 2.6% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 742,350,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 587.7M |
| Est. Threshold | HK$ 9.44B |
| Analysis Result | HK market cap below threshold, need +1507% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 溢利174.8百萬港元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
HKD
Income Statement
| Item | 2013-03 | 2014-03 | 2015-03 | 2015-09 |
|---|---|---|---|---|
| Revenue | 229,666,107 | 489,412,925 | 621,089,610 | 335,868,324 |
| Cost of sales | -42,276,993 | -42,901,302 | -47,585,730 | -22,255,312 |
| Other income and gains, net | 12,993,391 | 8,332,587 | 5,705,724 | 898,983 |
| Selling and distribution expenses | -28,434,139 | -23,805,197 | -23,928,266 | -16,955,502 |
| Net finance costs | -936,186 | -512,428 | -889,683 | 0 |
| Profit before tax | -31,203,783 | 96,668,611 | 210,596,799 | 104,348,484 |
| Income tax expense | 2,028,018 | 15,261,968 | 35,819,037 | 20,452,194 |
| Profit for the year | -33,231,801 | 81,406,643 | 174,777,762 | 83,896,290 |
| Profit attributable to owners | -32,301,003 | 81,121,682 | 174,415,159 | 83,471,177 |
Balance Sheet
| Item | 2013-03 | 2014-03 | 2015-03 | 2015-09 |
|---|---|---|---|---|
| Cash and cash equivalents | 52,605,992 | 74,822,200 | 129,884,745 | 323,724,341 |
| Trade and bills receivables | 32,514,921 | 21,371,440 | 22,123,781 | 26,778,536 |
| Inventories | 4,769,646 | 10,410,969 | 13,671,161 | 26,496,040 |
| Total current assets | 286,103,400 | 425,540,979 | 390,098,655 | 424,756,440 |
| Total current liabilities | 428,554,958 | 494,311,646 | 458,512,021 | 469,787,944 |
| Total equity | -98,316,225 | -16,920,701 | 2,953,861 | 22,438,571 |
| Equity attributable to owners | -96,951,819 | -15,820,529 | 3,691,430 | 22,751,026 |
| Interest-bearing borrowings | 15,714,976 | 24,640,301 | 0 | 0 |
Cash Flow Statement
| Item | 2013-03 | 2014-03 | 2015-03 | 2015-09 |
|---|---|---|---|---|
| Net cash from operating activities | 11,549,478 | 144,593,319 | 158,558,024 | 78,314,799 |
| Net cash from investing activities | -23,356,303 | -49,883,723 | 17,831,641 | 19,154,027 |
| Net cash from financing activities | 43,172,872 | -72,493,388 | -121,327,120 | 96,548,665 |
| Net increase in cash | 31,366,047 | 22,216,208 | 55,062,545 | 194,017,491 |
| Depreciation of PP&E | 9,631,538 | 15,319,312 | 17,707,725 | 10,557,602 |
| Amortisation of intangible assets | 127,375 | 390,177 | 445,145 | 265,494 |
| Purchase of PP&E | -21,590,920 | -28,359,869 | -23,996,509 | -7,913,532 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 2.98 |
|---|---|
| First Day Open | HK$ 3.1 |
| First Day Change | -1.65% |
| First Day Volume | 54949000.0 |
| First Day Turnover | 160996000.0 |
| Use of Proceeds | 1、約266.5百萬港元或約40%將用于在香港及大中華的其他地區成立新的醫學美容服務中心及診所以及通過有機增長擴大我們現有醫學美容服務中心及診所的規模;
2、約166.6百萬港元或約25%將用于在我們發現時機恰當時收購醫學美容中心及醫學美容診所及成立合營公司;
3、約66.6百萬港元或約10%將用于擴張我們的牙科服務業務;
4、約66.6百萬港元或約10%將用于設立我們的皮膚科相關業務線;
5、約33.3百萬港元或約5%將用于升級及提升我們的信息科技系統;
6、余額約66.6百萬港元或約10%將用于補充營運資金及用于其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Overall Coordinators (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (3)
Joint Lead Managers (3)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 昊海生物科技控股有限公司 | 77,698,290 HKD | — | 2.60% | — | 6 months | 2016-09-11 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 鄧志輝 | — |
| Company Secretary | 梁兆棋 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 鄧先生及Union Medical Care為控股股東,緊隨全球發售後(假設超額配股權並無獲行使)共同持有735,000,000股股份,佔已發行股本75%。 |
|---|




